BAYLOR COLLEGE OF MEDICINE
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1900-10-30
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.bcm.edu
Pregabalin in the Treatment of Essential Tremor
- First Posted Date
- 2008-03-28
- Last Posted Date
- 2021-04-26
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 20
- Registration Number
- NCT00646451
- Locations
- 🇺🇸
PDCMDC 6550 Fannin, Suite 1801, Houston, Texas, United States
Namenda (Memantine) for Non-motor Symptoms in Parkinson's Disease
- First Posted Date
- 2008-03-28
- Last Posted Date
- 2022-12-13
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 40
- Registration Number
- NCT00646204
- Locations
- 🇺🇸
PDCMDC 6550 Fannin, Suite 1801, Houston, Texas, United States
Trial of Xyrem for Excessive Daytime Sleepiness and Sleep Disturbance in Parkinson's Disease (PD)
- First Posted Date
- 2008-03-24
- Last Posted Date
- 2022-10-06
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 30
- Registration Number
- NCT00641186
Effect of Short Term Atorvastatin Treatment,80mg/Day on Early Regression of Carotid Artery Atherosclerotic Lesions
- First Posted Date
- 2008-03-21
- Last Posted Date
- 2010-12-07
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 12
- Registration Number
- NCT00640744
- Locations
- 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
Time to Defibrillation Using Automated External Defibrillators by Pediatric Residents in Simulated Cardiac Arrests
- Conditions
- Pediatric Residents
- Interventions
- Device: Manual defibrillatorDevice: Automated external defibrillator
- First Posted Date
- 2008-03-21
- Last Posted Date
- 2020-11-12
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 60
- Registration Number
- NCT00640354
- Locations
- 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
Acamprosate for Treatment of Compulsive Behaviors and Craving in Parkinson's Disease
- Conditions
- Parkinson's Disease
- First Posted Date
- 2008-03-21
- Last Posted Date
- 2015-11-13
- Lead Sponsor
- Baylor College of Medicine
- Registration Number
- NCT00640952
- Locations
- 🇺🇸
PDCMDC 6550 Fannin, Suite 1801, Houston, Texas, United States
Selegiline to Zelapar Switch Study in Parkinson Disease Patients
- First Posted Date
- 2008-03-21
- Last Posted Date
- 2023-08-09
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 48
- Registration Number
- NCT00640159
- Locations
- 🇺🇸
Stuart Isaacson, MD at Parkinson's Disease and Movement Disorder Center of Boca Raton, Boca Raton, Florida, United States
🇺🇸R. Malcolm Stewart, MD at Neurology Specialists of Dallas, Dallas, Texas, United States
🇺🇸PDCMDC 6550 Fannin, Suite 1801, Houston, Texas, United States
Ziprasidone in Pediatric Bipolar Disorder
- First Posted Date
- 2008-02-25
- Last Posted Date
- 2019-10-22
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 28
- Registration Number
- NCT00622739
- Locations
- 🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States
Vaccine Therapy in Treating Patients With Metastatic, Progressive Prostate Cancer
- Conditions
- Prostate Cancer
- Interventions
- Biological: NY-ESO-1/LAGE-1 HLA class I/II peptide vaccine
- First Posted Date
- 2008-02-15
- Last Posted Date
- 2012-11-06
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 14
- Registration Number
- NCT00616291
- Locations
- 🇺🇸
Dan L. Duncan Cancer Center at Baylor College of Medicine, Houston, Texas, United States
T-Lymphocytes in Treating Patients With Epstein-Barr Virus-Positive Nasopharyngeal Cancer, NPC
- Conditions
- Head and Neck Cancer
- Interventions
- Biological: autologous EBV specific CTLs
- First Posted Date
- 2008-02-06
- Last Posted Date
- 2012-10-10
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 25
- Registration Number
- NCT00609219
- Locations
- 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
🇺🇸The Methodist Hospital, Houston, Texas, United States